Amgen Inc.
AMGN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $151,823,600 | $150,214,980 | $167,613,900 | $140,880,414 |
| - Cash | $9,445,000 | $8,028,000 | $8,810,000 | $11,973,000 |
| + Debt | $54,587,000 | $56,204,000 | $57,381,000 | $60,099,000 |
| Enterprise Value | $196,965,600 | $198,390,980 | $216,184,900 | $189,006,414 |
| Revenue | $9,557,000 | $9,167,000 | $8,149,000 | $9,086,000 |
| % Growth | 4.3% | 12.5% | -10.3% | – |
| Gross Profit | $6,475,000 | $6,156,000 | $5,181,000 | $5,974,000 |
| % Margin | 67.8% | 67.2% | 63.6% | 65.7% |
| EBITDA | $5,913,000 | $3,617,000 | $4,083,000 | $2,926,000 |
| % Margin | 61.9% | 39.5% | 50.1% | 32.2% |
| Net Income | $3,216,000 | $1,432,000 | $1,730,000 | $627,000 |
| % Margin | 33.7% | 15.6% | 21.2% | 6.9% |
| EPS Diluted | 5.93 | 2.65 | 3.2 | 1.16 |
| % Growth | 123.8% | -17.2% | 175.9% | – |
| Operating Cash Flow | $4,684,000 | $2,280,000 | $1,391,000 | $4,771,000 |
| Capital Expenditures | -$436,000 | -$369,000 | -$411,000 | -$371,000 |
| Free Cash Flow | $4,248,000 | $1,911,000 | $980,000 | $4,400,000 |